questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Indolizine
Indolizidines
Alcaloïdes indoliques
Alcaloïdes formés par condensation de sécologanine et de tryptamine
Alcaloïdes de Vinca
Vincristine
Vincristine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
2
Vincristine
Cancer
Diagnostic
Tests de laboratoire
Imagerie médicale
Vincristine
Symptômes
2
Effets secondaires
Neuropathie
Vincristine
Douleur
Neuropathie
Vincristine
Prévention
2
Prévention
Effets secondaires
Vincristine
Évaluation médicale
Vincristine
Préparation au traitement
Traitements
2
Chimiothérapie
Vincristine
Prednisone
Administration intraveineuse
Vincristine
Chimiothérapie
Complications
2
Complications
Infections
Vincristine
Problèmes cardiaques
Vincristine
Surveillance médicale
Facteurs de risque
2
Facteurs de risque
Neuropathie
Vincristine
Antécédents médicaux
Vincristine
Neurologie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vincristine : Questions médicales les plus fréquentes",
"headline": "Vincristine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vincristine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-27",
"dateModified": "2025-02-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vincristine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Alcaloïdes de Vinca",
"url": "https://questionsmedicales.fr/mesh/D014748",
"about": {
"@type": "MedicalCondition",
"name": "Alcaloïdes de Vinca",
"code": {
"@type": "MedicalCode",
"code": "D014748",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.496.500.500.681.827"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vincristine",
"alternateName": "Vincristine",
"code": {
"@type": "MedicalCode",
"code": "D014750",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Wenjian Yang",
"url": "https://questionsmedicales.fr/author/Wenjian%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Deqing Pei",
"url": "https://questionsmedicales.fr/author/Deqing%20Pei",
"affiliation": {
"@type": "Organization",
"name": "Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Cheng Cheng",
"url": "https://questionsmedicales.fr/author/Cheng%20Cheng",
"affiliation": {
"@type": "Organization",
"name": "Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "William E Evans",
"url": "https://questionsmedicales.fr/author/William%20E%20Evans",
"affiliation": {
"@type": "Organization",
"name": "Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Richard H Ho",
"url": "https://questionsmedicales.fr/author/Richard%20H%20Ho",
"affiliation": {
"@type": "Organization",
"name": "Vanderbilt University Medical Center, Nashville, TN."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Sepsis in surgical patients: Burn sepsis.",
"datePublished": "2023-12-27",
"url": "https://questionsmedicales.fr/article/38154995",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.surg.2023.11.035"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of Sepsis-1 and Sepsis-3 Diagnostic Criteria in Patients with Sepsis in Intensive Care Unit.",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37457495",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2023/3794886"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Regulation of Neutrophil Migration in Patients with Sepsis: The Complexity of the Molecular Mechanisms and Their Modulation in Sepsis and the Heterogeneity of Sepsis Patients.",
"datePublished": "2023-03-24",
"url": "https://questionsmedicales.fr/article/37048076",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells12071003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sepsis heterogeneity.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36735197",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12519-023-00689-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Therapy of sepsis].",
"datePublished": "2023-01-09",
"url": "https://questionsmedicales.fr/article/36623529",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1813-2319"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Indolizine",
"item": "https://questionsmedicales.fr/mesh/D007212"
},
{
"@type": "ListItem",
"position": 6,
"name": "Indolizidines",
"item": "https://questionsmedicales.fr/mesh/D054836"
},
{
"@type": "ListItem",
"position": 7,
"name": "Alcaloïdes indoliques",
"item": "https://questionsmedicales.fr/mesh/D026121"
},
{
"@type": "ListItem",
"position": 8,
"name": "Alcaloïdes formés par condensation de sécologanine et de tryptamine",
"item": "https://questionsmedicales.fr/mesh/D046948"
},
{
"@type": "ListItem",
"position": 9,
"name": "Alcaloïdes de Vinca",
"item": "https://questionsmedicales.fr/mesh/D014748"
},
{
"@type": "ListItem",
"position": 10,
"name": "Vincristine",
"item": "https://questionsmedicales.fr/mesh/D014750"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vincristine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vincristine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vincristine",
"description": "Comment la vincristine est-elle utilisée dans le diagnostic ?\nQuels tests précèdent l'administration de vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Sepsis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vincristine",
"description": "Quels sont les effets secondaires de la vincristine ?\nLa vincristine cause-t-elle des douleurs ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Sepsis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vincristine",
"description": "Peut-on prévenir les effets secondaires de la vincristine ?\nY a-t-il des recommandations avant le traitement par vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Sepsis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vincristine",
"description": "Avec quels médicaments la vincristine est-elle souvent combinée ?\nComment la vincristine est-elle administrée ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Sepsis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vincristine",
"description": "Quelles complications peuvent survenir avec la vincristine ?\nLa vincristine peut-elle causer des problèmes cardiaques ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Sepsis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vincristine",
"description": "Qui est à risque d'effets indésirables de la vincristine ?\nLes antécédents médicaux influencent-ils le traitement par vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Sepsis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la vincristine est-elle utilisée dans le diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vincristine n'est pas un outil de diagnostic, mais un traitement pour des cancers diagnostiqués."
}
},
{
"@type": "Question",
"name": "Quels tests précèdent l'administration de vincristine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des examens d'imagerie sont effectués pour évaluer la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la vincristine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent neuropathie, constipation, et fatigue."
}
},
{
"@type": "Question",
"name": "La vincristine cause-t-elle des douleurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des douleurs neuropathiques chez certains patients."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les effets secondaires de la vincristine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures préventives incluent une surveillance étroite et des médicaments pour les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations avant le traitement par vincristine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une évaluation médicale complète est recommandée avant le traitement."
}
},
{
"@type": "Question",
"name": "Avec quels médicaments la vincristine est-elle souvent combinée ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est souvent combinée avec la prednisone et d'autres agents chimiothérapeutiques."
}
},
{
"@type": "Question",
"name": "Comment la vincristine est-elle administrée ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vincristine est administrée par voie intraveineuse, généralement en cycle."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la vincristine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections, des troubles neurologiques et des problèmes gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "La vincristine peut-elle causer des problèmes cardiaques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que rare, des problèmes cardiaques peuvent survenir, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'effets indésirables de la vincristine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients âgés et ceux avec des antécédents de neuropathie sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le traitement par vincristine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies neurologiques peuvent affecter le traitement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Vanderbilt University Medical Center, Nashville, TN.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.
High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.
High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Mental Health Institute of the Second Xiangya Hospital, Central South University, Chinese National Clinical Research Center on Mental Disorders (xiangya), Chinese National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health, Changsha, Hunan 410011, China.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States.
Center for Lung Regenerative Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Division of Pulmonary and Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Vincristine" :
Patients with large burn injuries remain a challenge. The loss of skin barrier integrity and induced immunosuppression after injury increases their vulnerability to infection. Sepsis remains the prima...
The use of SIRS and SOFA criteria in diagnosing sepsis among patients has been characterized by increasingly growing criticism. Indeed, the definition of sepsis has attracted significant controversy i...
The study used the Medical Information Mart for Intensive Care-III (MIMIC-III) database in assessing the effectiveness of the SIRS and SOFA diagnostic criteria. It ascertained the severity and specifi...
The analysis of data for this study was based on the chi-square test, which is significant in comparing the specificity, mortality, and sensitivity of the data. The process of screening the MIMIC-III ...
The study results also portray numerous challenges in using the sepsis-3 criteria as a diagnostic tool. In particular, the ICD-10-CM diagnosis approach was limiting because it inhibited the measure of...
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Common causes include gram-negative and gram-positive bacteria as well as fungi. Neutrophil...
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, with extremely high mortality. Notably, sepsis is a heterogeneous syndrome characterized by a vast, ...
We used PubMed to search the subject-related medical literature by searching for the following single and/or combination keywords: sepsis, heterogeneity, personalized treatment, host response, infecti...
We found that host factors (age, biological sex, comorbidities, and genetics), infection etiology, host response dysregulation and multiple organ dysfunctions can all result in different disease manif...
Herein, we have summarized contributing factors to sepsis heterogeneity, including host factors, infection etiology, host response dysregulation, and multiple organ dysfunctions, from the key elements...
Sepsis as a development of an acute infection-related organ dysfunction significantly increases the risk of death for the patient. Therefore, fast and consistent management is required. The sepsis bun...
Sepsis is a life-threatening organ dysfunction resulting from dysregulated host responses to infection. Macrophages play significant roles in host against pathogens and the immunopathogenesis of sepsi...
Sepsis is a hyper-heterogeneous syndrome in which the systemic inflammatory response persists throughout the course of the disease and the inflammatory and immune responses are dynamically altered at ...
Up to now, sepsis is one of the most threatening diseases and its therapy remains challenging. Sepsis is currently defined as a severely dysregulated immune response to an infection resulting in organ...
The Epic Sepsis Prediction Model (SPM) is a proprietary sepsis prediction algorithm that calculates a score correlating with the likelihood of an International Classification of Diseases, Ninth Revisi...
This study aimed to assess the clinical impact of an electronic sepsis alert and navigator using the Epic SPM on time to initial antimicrobial delivery....
We performed a retrospective review of a nonrandomized intervention of an electronic sepsis alert system and navigator using the Epic SPM. Data from the SPM site (site A) was compared with contemporan...
A total of 5368 admissions met inclusion criteria. Time to initial antimicrobial delivery from emergency department arrival was 3.33 h (interquartile range [IQR] 2.10-5.37 h) at site A, 3.22 h (IQR 1....
Implementation of an electronic sepsis alert system plus navigator using the Epic SPM showed no difference in time to initial antimicrobial delivery between the contemporaneous SPM alert plus sepsis n...
Purpose: To evaluate significant risk variables for sepsis incidence and develop a predictive model for rapid screening and diagnosis of sepsis in patients from the emergency department (ED). Methods:...